and the ‡ ‡IACR-Rothamsted, Harpenden, AL5 2JQ, United Kingdom CYP83B1 from Arabidopsis thaliana has been identified as the oxime-metabolizing enzyme in the biosynthetic pathway of glucosinolates. Biosynthetically active microsomes isolated from Sinapis alba converted p-hydroxyphenylacetaldoxime and cysteine into S-alkylated p-hydroxyphenylacetothiohydroximate, S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine, the next proposed intermediate in the glucosinolate pathway. The production was shown to be dependent on a cytochrome P450 monooxygenase. We searched the genome of A. thaliana for homologues of CYP71E1 (P450ox), the only known oxime-metabolizing enzyme in the biosynthetic pathway of the evolutionarily related cyanogenic glucosides. By a combined use of bioinformatics, published expression data, and knock-out phenotypes, we identified the cytochrome P450 CYP83B1 as the oxime-metabolizing enzyme in the glucosinolate pathway as evidenced by characterization of the recombinant protein expressed in Escherichia coli. The data are consistent with the hypothesis that the oxime-metabolizing enzyme in the cyanogenic pathway (P450ox) was mutated into a "P450mox" that converted oximes into toxic compounds that the plant detoxified into glucosinolates.Glucosinolates are naturally occurring amino acid-derived S-glucosides of thiohydroximate-O-sulfonates. They co-occur with endogenous thioglucosidases called myrosinases that upon tissue damage hydrolyze glucosinolates into a wide range of degradation products such as e.g. isothiocyanates, nitriles, and thiocyanates. Glucosinolates (or rather their degradation products) are involved in plant defense and constitute characteristic flavor compounds and cancer-preventive agents in Brassica vegetables.The biosynthetic pathway from precursor amino acid to the core glucosinolate structure has been well studied, and many of the intermediates are known, including oximes, thiohydroximic acids, and desulfoglucosinolates (1, 2). Recently, it has been shown that cytochromes P450 belonging to the CYP79 family catalyze the conversion of amino acids to oximes (3-7). Little is known about the formation of thiohydroximic acids from oximes. The remaining part of the pathway for the core structure involves a UDP-glucose:thiohydroximic acid glucosyltransferase and a sulfotransferase (for review, see Ref.2).It has been proposed that aci-nitro compounds are intermediates in the conversion of oximes to thiohydroximic acids (8). This was supported by isolation of 1-nitro-2-phenylethane from Tropaeolum majus shoots and by in vivo conversion of phenylacetaldoxime into 1-nitro-2-phenylethane and of 1-nitro-2-[1,2-14 C]phenylethane into benzylglucosinolate (9). The aci-nitro is proposed to be conjugated with a sulfur donor to produce an S-alkyl thiohydroximate, possibly by a glutathione S-transferase (2). Biochemical studies indicate that the S-alkyl thiohydroximate is subsequently hydrolyzed to the thiohydroximic acid by a C-S lyase (10).Glucosinolates are related to cyanogenic glucosides because both...